Table of contents:
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Type of Product
6.1 Instruments
6.2 Softwares
6.3 Fluorospheres
6.4 Instrument Support Reagents
6.5 Reagents
6.6 Systems and Kits
6.7 Others
Chapter 7 Market Segmentation, By Technology
7.1 Bead-based Flow Cytometry
7.2 Cell-based Flow Cytometry
7.3 Others
Chapter 8 Market Segmentation, By Application
8.1 Life Sciences and Biotechnology (Research and Development)
8.1.1 Intracellular Calcium flux
8.1.2 Cell Proliferation Assay
8.1.3 Apoptosis
8.1.4 Cell cycle analysis
8.1.5 Cell Sorting
8.1.6 Immunophenotyping
8.2 Clinical Applications
8.2.1 Blood Transfusion
8.2.2 HIV
8.2.3 Stem Cell
8.2.4 Organ Transplantation
8.2.5 Detection of minimal Residue disease
8.2.6 Oncology
8.3 Others
Chapter 9 Market Segmentation, By End-Users
9.1 CRO
9.2 Pharmaceuticals
9.3 Biotechnology
9.4 Academia
9.5 Hospitals
Chapter 10 Market Segmentation, By Geography
10.1 North America
10.1.1 Introduction
10.1.2 United States
10.1.3 Canada
10.1.4 Mexico
10.1.5 Others
10.2 Europe
10.2.1 Introduction
10.2.2 U.K
10.2.3 Spain
10.2.4 Italy
10.2.5 France
10.2.6 Russia
10.2.7 Others
10.3 Asia-Pacific
10.3.1 Introduction
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 Australia
10.3.6 Others
10.4 South America
10.4.1 Introduction
10.4.2 Brazil
10.4.3 Argentina
10.4.4 Others
10.5 The Middle East & Africa
10.5.1 Introduction
10.5.2 South Africa
10.5.3 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profiles
12.1. Luminex Corporation
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Strategic Initiative
12.2. TTP Labtech Ltd
12.3. Partec GMBH
12.4. Miltenyi Biotech
12.5. Bio-Rad Laboratories
12.6. Life Technologies
12.7. EMD Millipore
12.8. Beckman Coulter
12.9. Becton, Dickinson and Company
12.10. Thermo Fisher Scientific, Inc.
12.11. Merck KGAA
12.12. Affymetrix, Inc.
12.13. Sysmex Partec GmbH
12.14. Sony Biotechnology Inc.
12.15. Danaher Corporation
Chapter 13 Market Estimates and Forecast
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Type of Product 2018-2024 (USD Million)
13.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
13.1.1 Market Estimation and Forecast by Application 2018-2024 (USD Million)
13.1.1 Market Estimation and Forecast by End-Users 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures